Work

Efficacy of 0.05% Topical Tretinoin to Treat Glucocorticoid‐Induced Skin Atrophy in a Self‐Controlled Case Study

Year: 2025

Type: article

Abstract: This self-controlled case study demonstrates the therapeutic potential of 0.05% topical tretinoin for glucocorticoid-induced skin atrophy. The patient experienced marked improvements in skin resilience and appearance, as evidenced by reduced bruising, improved skin elasticity, and increased patient satisfaction. Given this condition's lack of effective treatments, the findings could offer a promising therapeutic option.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.71003

Authors: Mathijs M. Goossens, Eliane Kellen, Georges Hatem

Institutions: Universitair Ziekenhuis Brussel, Universitair Ziekenhuis Leuven, Lebanese University

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,820